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KAREN ROTHENBERG: 
PRESCIENT, PERCEPTIVE, 
PERSISTENT AND PASSIONATE 
DIANE E. HOFFMANN, J.D., M.S. 
This issue of the Journal of Health Care Law & Policy is dedicated to the 
legacy of Professor Karen Rothenberg as a health law scholar, teacher, mentor 
and founder of the Law & Health Care Program (L&HCP) at the University of 
Maryland Francis King Carey School of Law.  The issue includes twelve 
articles/essays from individuals whose professional careers have been touched 
by Professor Rothenberg in some way. They are from former students (Fuller, 
Ulrich, and Walman), senior health law professors who Karen mentored early in 
their careers (Charo and Clayton), mid-career health law professors who 
benefited from Karen’s sage advice when they were just starting out (Roberts 
and Rebouche), current colleagues (Pasquale), co-workers or collaborators on 
policy and educational initiatives (Berkman, Brody, Collins, Green, Faden and 
Schwartz), and co-authors (Bush, Charo, Fuller, Rebouche, and Ulrich). They 
are just a small sampling of the many people who have had the good fortune to 
interact with Karen during her time in the academy. 
I write this introductory essay as someone who was mentored by Karen, 
who has benefited from Karen’s wisdom and advocacy throughout my career, 
collaborated with her on policy initiatives, co-authored articles with her, worked 
for her as Associate Dean when she was Dean, co-taught courses with her, and 
who has been her colleague and friend for over 30 years. I met Karen in 1987 
when I was interviewing for a faculty position at Maryland. At the time I was 
practicing at a law firm in Washington, D.C. and was not quite sure that I was 
ready to go into academia. But after meeting Karen, there was no way I could 
give up an opportunity to work with this brilliant, creative and passionate 
woman.  I was offered the position and immediately accepted it and have never 
regretted that decision for an instant. 
I. KAREN ROTHENBERG IN FOUR “P”S 
The title of this article has two origins. First, it stems from one of the many 
things Karen taught me: people will remember what you have to say much better 
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if you use alliteration; thus the four “P”s: Prescient, Perceptive, Persistent and 
Passionate. In fact, every year when Karen was Dean and spoke to the incoming 
class at orientation, she would talk about the five “P”s that you need to have a 
successful experience in law school and in a legal career: People, 
Professionalism, Participation, Perspective, and Passion. Second, it grew out of 
the common characteristics that the authors of the dozen essays in this tribute 
highlighted about Karen.  
Karen has been prescient about health law since before the area was a field 
of practice and the authors in this issue consistently mentioned Karen as both 
forward looking and as able to see into the future, at least as to what the future 
might bring in health law. Karen went to law school at the University of Virginia 
and was a student of the late Professor Walter Wadlington.  Wadlington had this 
to say about Karen when she became Dean at Maryland: “While she was at 
Virginia, Karen was one of my favorite students because of her effervescent 
personality and her keen interest in developments in medicine and medical 
practice and what they might hold for law in the health care field.”1 After 
graduating from law school, Karen worked for the law firm of Covington & 
Burling, in Washington, D.C., where Charles Miller was her mentor. Reflecting 
on her time at the firm, Miller said:  
 I always knew that Karen was destined to be a leader in health law 
when she joined our firm in 1979 and told me she wanted to develop 
a health law practice before we knew there was such a field as health 
law.  Karen had the vision to see that we were then on the brink of a 
great development in this field, and the energy to convert that vision 
into reality.  Her decision to join the UM faculty and head up the Law 
& Health Care Program when no one could have told you what such 
a program really would or should entail further illustrates that she was 
a true pioneer and destined for great accomplishments.  It all looks 
inevitable now, but it did not seem so then.2 
The second “P” about Karen is that she is very perceptive, a good quality 
to have as a law professor and scholar and the reason many people sought her 
out as a mentor. She is able to simplify complex legal and scientific issues and 
see things that are not obvious to others. She can cut through all the weeds 
quickly and skillfully and get to the heart of an issue. She sees the need for 
nuanced solutions and is able to see a problem from multiple perspectives. She 
 
 1. E-mail from from Professor Walter Wadlington, University of Virginia School of Law, to Diane 
E. Hoffmann, Jacob A. France Professor of Health Law; Director, Law & Health Care Program, University 
of Maryland Francis King Carey School of Law, circa 1999, on the occasion of Prof. Rothenberg stepping 
down as Director of the Law & Health Care Program and becoming Dean..  
 2. E-mail from Charles Miller, Senior Counsel, Covington, to Diane Hoffmann, Jacob A. France 
professor of Health Law, Director, Law & Health Care Program, University of Maryland Francis King 
Carey School of Law,  circa 1999, on the occasion of Prof. Rothenberg stepping down as Director of the 
Law & Health Care Program and becoming Dean.  
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is a master at solving problems that others find intractable. An example of this 
was her work on genetic discrimination. Her insights that genetic test results 
could ultimately be used by insurers and employers to deny individuals insurance 
or employment and thus discourage individuals from participating in genetic 
research ultimately led to the passage of the Genetic Information 
Nondiscrimination Act (GINA). Without this law, as pointed out by Berkman, 
Brody, Collins and Green,3 the field of genomics research may have been much 
slower to develop.  
While prescience and perceptiveness are two of Karen’s strengths, she is 
also persistent about making her point. She never gives up trying to get you to 
see her perspective nor backs down when challenged. This persistence may stem 
from the character trait that comes up most often when people talk about Karen, 
i.e., her passion. This trait was mentioned by a number of the tribute authors. 
Whether it is a passion for women’s issues, genetic privacy, or theater, passion 
seems to ooze through her veins. She uses that passion to zealously advocate for 
a position or person with the intensity of a dog with a bone, not willing to stop 
until she has gotten you to agree with her, and the amazing thing about her is that 
she gets you to think it was your idea in the first place! 
Two additional words that describe Karen, that I did not include in the title 
simply because it would have been ridiculously long but that are in keeping with 
the alliteration theme, are “partner” and “pal.” Several commenters in this issue 
mention how Karen mentored them not so much as a teacher, but rather as an 
equal or partner. That was especially the case when she was co-authoring a piece 
with a junior faculty member or with a student research assistant. But the word 
partner also describes Karen’s penchant for collaboration not only with 
individuals, but also with institutions. As the founding Director of Maryland’s 
Law & Health Care Program, she sought to collaborate with the health science 
schools on our campus, as well as with Johns Hopkins University, on both 
educational and research initiatives. As Dean, she channeled her love of theater 
to partner with Baltimore theaters on a program called “Linking Law & the 
Arts.”4  After her Deanship, she developed partnerships between the L&HCP and 
the Berman Bioethics Institute at Johns Hopkins University, helping to establish 
a dual degree program in law and bioethics, and between the L&HCP and the 
National Human Genome Research Institute (NHGRI) at the National Institutes 
of Health (NIH), offering an innovative new course and externship for law 
students. 
 
 3. Benjamin E. Berkman, et al., Tribute Essay, Karen Rothenberg’s (Not So) Secret Roles and 
Contributions at the U.S. National Institutes of Health, 22 J. OF HEALTH CARE L. AND POL’Y (2019). 
 4. Linking Law & the Arts, UNIVERSITY OF MARYLAND FRANCIS KING CAREY SCHOOL OF LAW 
(last visited August 16, 2019), https://www.law.umaryland.edu/Programs-and-Impact/Other-
Initiatives/Linking-Law—the-Arts/ 
  
144 JOURNAL OF HEALTH CARE LAW & POLICY [VOL. 22:141 
The final word that describes Karen is “pal” or, more appropriately, friend. 
Even after meeting Karen for the first time, you feel as though you have made a 
new friend. She not only wants to know what you are writing about, she wants 
to know what is important to you – your family, your children, your friends, your 
ideas and beliefs. She effortlessly makes a connection with you and once she 
does, she is there for you in good times and bad.    
II. A CAREER IN THREE PARTS 
Part One 
Karen started at the law school in 1983, just a few years before me, with a 
plan to develop and grow a law and health care program. In large part, I was 
hired to help her. For the next dozen years, we worked closely together as 
colleagues building the program, teaching and working on our scholarship. As 
an assistant professor, Karen was incredibly prolific and, it seemed to me when 
I arrived, had already made a name for herself in the health law and policy 
academy. In the first four years of her professorship she had been a legal 
consultant for the American College of Nurse-Midwives, served on an NIH 
consensus panel on the use of diagnostic ultrasound imaging in pregnancy, and 
led a Task Force to plan a forum held by NIH and the International Childbirth 
Education Association on Medical Malpractice Issues in Obstetrics. After I 
started, she somehow seemed to pick up the pace of her work. During the next 
eight years she served on numerous boards, advisory and planning committees, 
and as an officer or leader in a number of health law organizations. These 
positions included the Board of Directors of the National Health Law Program; 
Chair of the AALS section on Law, Medicine & Health Care; and member of the 
Institute of Medicine’s (IOM’s) Committee on Legal and Ethical Issues Relating 
to the Inclusion of Women in Clinical Studies. Ruth Faden, in her essay, recounts  
meeting Karen when they both served on this IOM Committee. She remarked 
that “[t]wo of Karen’s abiding passions, advancing the rights and interests of 
women and advancing more ethical public polices, were front and center in the 
work of this committee.”5 
While in this nascent phase of her career, Karen was an active researcher 
and scholar.  Her early scholarship focused on the right to forego life-sustaining 
treatment, medical decision-making for children, the rights of health care 
workers when treating individuals with acquired immunodeficiency syndrome 
(AIDS), and the evolution of the legal duty to provide emergency care. She 
served as the principal investigator on a grant from the American Foundation for 
AIDS Research to examine the connection between partner notification, 
violence, and women with AIDS or Human Immunodeficiency Virus (HIV). 
 
 5. Ruth Faden, Tribute Essay, Tribute to Karen, 22 J. OF HEALTH CARE L. AND POL’Y (2019). 
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Through two cases handled at the law school’s AIDS/HIV clinic, where the 
clients were women who had tested positive for HIV, Karen learned that 
notification by physicians or public health officers to the sexual or needle-sharing 
partners of such individuals led to domestic violence (shooting) in one case and 
abandonment in another. Such notification was recommended by the CDC at this 
time. However, Karen’s research and scholarship6 informed and supported 
changes in partner notification protocols at the federal7 and state levels.8 
Early on in her career, Karen developed a relationship with a number of 
researchers and policy makers at NIH and spent several sabbaticals and leaves 
(under the Intergovernmental Personnel Act) at different Institutes there. The 
first was in the spring of 1991 when she worked at the National Institute for Child 
Health and Human Development. In the course of her work there, she met 
Elizabeth Thompson and became very interested in newly available prenatal 
genetic tests and the profound issues they raised for pregnant women. This 
experience was to be the foundation for much of her early and long-term 
scholarship. During this time, Karen was focused primarily on women’s health 
and reproductive issues and published articles on surrogacy, low income women 
and medical malpractice, the “good mother”, and women in clinical trials. With 
the coming of the genetic revolution, Karen became embroiled in the world of 
prenatal genetic testing, co-editing her first book (with Elizabeth Thomson) on 
that topic.9 It was this work that led to what has become the scholarship for which 
she is most well-known: legal issues in research and clinical practice involving 
genetic testing and treatment.   
At this time, Karen was also a member and then President of the Board of 
Directors of the American Society of Law, Medicine & Ethics (ASLME). During 
her tenure as President, Karen oversaw a milestone leadership transition and 
worked with other members to establish a peer review process for articles 
published in the Journal of Law, Medicine & Health Care (now the Journal of 
Law, Medicine & Ethics). Although having only been a health law professor for 
a decade, in 1994 she was selected as one of the earliest recipients of ASLME’s 
prestigious Jay Healey Health Law Teacher’s Award.10 
 
 6. Richard North & Karen H. Rothenberg, Partner Notification and the Threat of Domestic Violence 
Against Women with HIV Infection, 329 NEW ENGLAND J. MED. 1194 (1993). 
 7. CTR. DISEASE CONT. PREVENTION, DATA SECURITY AND CONFIDENTIALITY GUIDELINES FOR 
HIV, VIRAL HEPATITIS, SEXUALLY TRANSMITTED DISEASE, AND TUBERCULOSIS PROGRAMS 20 (2011). 
 8. MD. CODE ANN., HEALTH–GEN. § 18-201.1(d)(1)(i) (West 2019).  Prior to Karen’s research, 
Maryland law required physicians to contact needle-sharing and sexual partners of their patients who were 
HIV positive.  After it came to light that women were being abused when their male partners were 
informed of the HIV status of their female partner, the Maryland General Assembly changed the law to 
give physicians the discretion as to whether to notify their female patients’ male partners.  Id. 
 9. WOMEN AND PRENATAL TESTING: FACING THE CHALLENGES OF GENETIC TECHNOLOGY (Karen 
H. Rothenberg & Elizabeth Jean Thomson, eds., 1994). 
 10. The Jay Healey Award, AM. SOC. OF L., MED. & ETHICS, (last visited Aug. 16, 2019), 
https://aslme.org/calendar/jay-healey-award/. 
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In the early 1990s, Karen also worked closely with me as I led a coalition 
of stakeholder groups to change and expand the law in Maryland regarding 
decision-making for life sustaining treatment when patients are terminally ill, in 
a persistent vegetative state or have an “end-stage condition.” We developed a 
legislative proposal that was the subject of significant debate and controversy in 
the Maryland General Assembly. Karen’s guidance and advice during this 
monumental effort was both inspired and strategic. Jack Schwartz, in his essay, 
describes how Karen had a clear “reading of the legislative and public mood at a 
time when end-of-life policy making was in flux.”11 She was able to see what 
was at issue for families under the prior law that required them to go to court in 
order to disconnect a loved one from a ventilator or feeding tube. She realized 
such a requirement was emotionally heart wrenching for them and knew no one 
wanted to go to court at the time a beloved family member was dying. She 
successfully and passionately made that argument in her testimony before the 
Maryland General Assembly, which then passed the Health Care Decisions Act.  
Subsequently, she spent an academic year (Sept. 1995 – May 1996) at 
NIH’s Office of Research on Women’s Heath as a Special Assistant to the 
Director, Vivian Pinn. There she continued her work on the inclusion of women 
in clinical trials12 and expanded her scholarship on genetic issues. From 1995 to 
1999, Karen published numerous articles on such topics as genetic 
discrimination and health insurance,13 the challenge of too much genetic 
information,14 genetic information and the workplace,15 cancer genetic 
susceptibility testing,16 privacy in genetics research,17 and cloning.18 While 
writing in this area she also served on a number of relevant panels and work 
groups. For example, she served on the Working Group on Ethical, Legal and 
Social Implications of Human Genome Research, on the Ethical Issues 
Committee on Tissue Banks and the Biological Resources Working Group for 
the National Action Plan on Breast Cancer, and as a member of the Recombinant 
 
 11. Jack Schwartz, Tribute Essay, Tribute to Professor Karen Rothenberg, 22 J. OF HEALTH CARE L. 
AND POL’Y (2019). 
 12. Karen R. Rothenberg, Gender Matters: Implications for Clinical Research and Women’s Health 
Care, 32 HOUSTON L. REV. 1201 (1996). 
 13. Kathy L. Hudson et al., Genetic Discrimination and Health Insurance: An Urgent Need for 
Reform, 270 SCIENCE 391 (1995). 
 14. Benjamin Wilfond, Elizabeth Thomson & Caryn Lerman, Cancer Genetics Susceptibility 
Testing: Ethical and Policy Implications for Future Research and Clinical Practice 25 J. OF L., MED. & 
ETHICS 243 (1997). 
 15. Karen Rothenberg et al., Genetic Information and the Workplace: Legislative Approaches and 
Policy Challenges, 275 SCIENCE 1755 (1997). 
 16. Benjamin S. Wilfond et al., Cancer Genetic Susceptibility Testing: Ethical and Policy 
Implications for Future Research and Clinical Practice, 25 J.L. MED. & ETHICS 243 (1997). 
 17. Barbara P. Fuller et al., Privacy in Genetics Research, 285 SCIENCE 1359 (1999). 
 18. Karen H. Rothenberg, “Being Human”: Cloning and the Challenges for Public Policy, 27 
HOFSTRA L. REV. 639 (1999). 
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DNA Advisory Committee at NIH. During this time, she also developed and 
honed certain positions on significant ethical issues created by genetic testing 
and genetic research. These included the idea that not all medical/genetic 
information is a good thing. This idea ran counter to the general medical view at 
the time that more information is better. However, Karen persuasively argued in 
a number of forums that sometimes people might not want to know that they are 
likely to develop a certain disease or disabling condition such as Huntington’s or 
Alzheimer’s, particularly when there is no cure for the disease.19 Subsequent 
research on this question continues to build on Karen’s early research and 
insights. 
Karen also had strong concerns about discrimination based on the results of 
genetic testing and published several articles in the prestigious journal, Science, 
about the potential use of genetic test results by health insurers to deny 
individuals insurance and by employers who might choose not to hire someone 
with a predisposition to a serious genetic disease.20 But Karen came to see that 
genetic testing could also lead to another type of discrimination, that against 
groups of individuals. For example, when it became clear that Ashkenazi Jewish 
women were more likely to carry the BRACA 1 gene that often leads to breast 
cancer, some may have assumed that all Ashkenazi Jewish women will develop 
the disease when, in fact, only a small percentage will do so. Ellen Clayton 
describes in her essay how Karen’s analysis on this topic “informed later 
discussions of how to prevent group harm, a gnarly and still unresolved 
dilemma.”21 
Part Two 
Karen’s concerns about the use of genetic test results to discriminate led 
her to help lay the groundwork for legislation at the federal and state levels that 
would prohibit the use of such test results by insurers and employers. However, 
her work on this important legislation was put on hold, but only momentarily, as 
she took over as Interim Dean (1999–2000) and then Dean (2000–2009) of the 
law school.22 During this time, Karen, still full of boundless energy, kept up her 
 
 19. Kimberly A. Quaid & Michael Morris, Reluctance to Undergo Predictive Testing: The Case of 
Huntington Disease, 45 AM. J. MED. GENETICS 41 (1993).   
 20. Rothenberg, supra note 12; Rothenberg, supra note 15. 
 21. Ellen Wright Clayton, Tribute Essay, Encomium to Karen Rothenberg, 22 J. OF HEALTH CARE 
L. AND POL’Y (2019). 
 22. While the work of Prof. Rothenberg as Dean was also noteworthy for her many 
accomplishments, this aspect of her time at the law school has been written about in a special issue of 
the Maryland Law Review.  Tributes were published by Martin J. O’Malley, former Governor of 
Maryland and former student of Prof. Rothenberg; Senator Benjamin Cardin (U.S. Senator for Maryland 
and Maryland alum); Robert M. Bell, former Chief Justice of the Maryland Court of Appeals, and Andre 
M. Davis, former United States Circuit Judge of the United States Court of Appeals for the Fourth 
Circuit and Maryland alum.  Martin J. O’Malley, Benjamin L. Cardin, Robert M. Bell, & Andre M. 
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work on legal and policy issues arising out of the developments in genetics. In 
particular, she continued her advocacy for GINA,23 which was ultimately passed 
by Congress in 2008,24 and worked with members of the Maryland General 
Assembly to pass similar legislation in Maryland.25 Several of the contributors 
to this issue describe Karen’s role in getting the federal legislation passed.26 
Jessica Roberts describes her as the “fairy godmother of genetics and the law.” 
While Karen was Dean and I was Associate Dean, we also worked together 
on a major empirical project looking at how health-related genetic test results 
were being used in the court room.27 We saw these as “second generation” 
genetic tests following on the heels of DNA tests used for determining identity 
in paternity and in some criminal litigation. We designed and conducted a survey 
of all state circuit court judges and federal district court judges in Maryland. 
Judges were asked about their prior use of genetic tests for identity purposes and 
whether they had had any requests to admit or compel health-related genetic tests 
in their court rooms. We then gave them a series of hypothetical cases where they 
were asked to respond to requests by one of the litigants to admit or compel such 
tests results. Through Karen’s role as Dean and her relationship with many 
judges in the state, we were able to obtain a very good response rate (72%). 
Collaboration with Karen on the interpretation of the data and writing of the 
article was an amazing experience. As Barbara Fuller, Karen’s former research 
assistant, stated in her essay for this issue about collaborating with Karen, “she 
was never content until all angles of an issue had been explored.”28 And the data 
we generated had many angles from which it could be interpreted. Truly the 
analysis and the article were much better for my collaboration with Karen.  
While serving as Dean, Karen somehow managed not only to sit on the 
newly established Maryland Stem Cell Commission, but also to chair it – a time 
consuming and demanding job. It was a significant role that required establishing 
all the procedures, protocols and policies by which the Commission would 
 
Davis, Tributes to Dean Karen H. Rothenberg, 68 MD. L. REV. 755 (2009). Available at: 
http://digitalcommons.law.umaryland.edu/mlr/vol68/iss4/3. 
 23. In this effort, Karen testified before the U.S. House of Representatives Subcommittee on Health, 
Employment, Labor and Pensions., Protecting Workers from Discrimination Before the H. Comm. on 
Educ. and Lab., 110th Cong. (2007) (statement of Karen H. Rothenberg, Dean, University of Maryland 
School of Law).  
 24. Genetic Information Nondiscrimination Act of 2008, 42 U.S.C. § 300gg-53 (2008). 
 25. MD. CODE ANN., INS. § 27-909 (West 2019). 
 26. See Barbara Fuller, Tribute Essay, My Incredible Journey with Karen, 22 J. OF HEALTH CARE L. 
AND POL’Y (2019); Benjamin E. Berkman, et al., Tribute Essay, Karen Rothenberg’s (Not So) Secret Roles 
and Contributions at the U.S. National Institutes of Health, 22 J. OF HEALTH CARE L. AND POL’Y (2019); 
Ellen Wright Clayton, Tribute Essay, Encomium to Karen Rothenberg, 22 J. OF HEALTH CARE L. AND 
POL’Y (2019). 
 27. Diane E. Hoffmann & Karen Rothenberg, Judging Genes: Judicial Response to the Second 
Generation of Genetic Tests, 66 MD. L. REV. 858 (2007). 
 28. Barbara Fuller, Tribute Essay, My Incredible Journey with Karen, 22 J. OF HEALTH CARE L. AND 
POL’Y (2019). 
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allocate a several million-dollar budget to Maryland scientists performing stem 
cell research. Jack Schwartz writes in his essay about the controversy that 
enshrouded a similar effort in California that “Karen had the discernment to 
know that the best path forward for the Maryland effort would be . . . quiet and 
steadfast professionalism – a scientifically sound grant review process, free of 
conflicts of interest and political agendas . . .”29 As the person who took Karen’s 
place on the Commission after her term of service, I can see the beneficial impact 
that Karen’s vision and characteristic strategic acumen had on the workings of 
the Commission.  
Part Three 
In the last phase of her career, since stepping down as Dean, Karen has 
married her love of theater with her passion for the ethical, legal and social issues 
arising out of research and clinical practice related to genetics and has devoted 
much of her scholarship to the use of plays to explore and mine those issues. She 
has written articles about plays that many of us have read or seen performed 
examining the scientific and ethical questions they raise, often foreshadowing 
some of the current dilemmas we face as a society regarding whether and how to 
regulate science.30 But she also sees them as vehicles for examining relationships 
in ways that the study of science alone may not allow. In his essay for this 
volume, Frank Pasquale writes about how “Rothenberg’s turn to literature 
recognizes that our plays and poems, stories and films, reveal patterns of power 
and meaning in the world by exploring the ramifications of critical relationships. 
They illuminate fundamental aspects of human experience.”31 While Karen 
explored the depths of existing literature to illustrate aspects of the human 
condition affected by science, she was not content to simply analyze the writings 
of others. In addition to her analysis, she co-authored several original plays 
designed specifically to examine some of the intractable dilemmas that current 
genetics research and clinical practice raise; issues like return of incidental 
findings,32 informed consent,33 discrimination,34 privacy,35 and relationships 
 
 29. Jack Schwartz, Tribute Essay, Tribute to Professor Karen Rothenberg, 22 J. OF HEALTH CARE L. 
AND POL’Y (2019). 
 30. See Karen H. Rothenberg, From Eugenics to the ‘New’ Genetics: ‘the Play’s the Thing’, 79 
FORDHAM L. REV. 407 (2010); Karen H. Rothenberg & Lynn W. Bush, Manipulating Fate: Medical 
Innovations, Ethical Implications, Theatrical Illuminations, 13 HOUS. J. HEALTH L. & POL’Y 1534 (2012).  
 31. Frank Pasqule, Tribute Essay, Bringing a Holistic Perspective to Law, Medicine, and the 
Humanities: A Tribute to Karen Rothenberg, 22 J. OF HEALTH CARE L. AND POL’Y (2019). 
 32. Lynn W. Bush & Karen H. Rothenberg, Dialogues, dilemmas, and disclosures: genomic research 
and incidental findings, 14 GENETICS IN MED.1 (2012). 
 33. Wilfond, supra note 16, at 244. 
 34. Rothenberg, supra note 15, at 1755. 
 35. Fuller, supra note 17, at 1359–60. 
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between family members.36 Often enlisting colleagues to play the actors in her 
theatrical productions, Karen used these plays as a way to generate conversations 
among scientists, bioethicists and health law academics, and to help researchers 
understand the difficult decisions patients must make as a result of new genetic 
information and technologies. Lynn Bush writes eloquently in her article for this 
issue about her collaboration with Karen on many of these plays and on their co-
authored book, The Drama of DNA.37 And, in personal correspondence to me, 
Professor Abbe Gluck described Karen’s work “using theatre as a pedagogical 
tool to inspire discussions on issues of genetic ethics and to engender empathy” 
as “groundbreaking.” 
Also, in this phase of her career, Karen was given a joint appointment at the 
Johns Hopkins Berman Institute. In her essay, Ruth Faden, former Director of 
the Institute, shares the role that Karen has played at the Institute over the last 
decade and the impact that she has had on many of the faculty and Fellows that 
have spent time there. And last but not least, over the time since her Deanship, 
Karen spent several years at NIH, as Senior Advisor to Eric Green, Director of 
NHGRI, and at the Clinical Center working with Ben Berkman and others. In 
their contribution to this issue, Green and Berkman, along with NIH Director 
Francis Collins and NHGRI Senior Investigator Lawrence Brody share the roles 
Karen has held at, and contributions she has made to, NIH. One of those roles is 
“educator.” They describe how Karen developed “the idea for an intensive 
workshop where students would research and analyze a range of ethical, legal 
and policy questions raised by the increasing prevalence of human genome 
sequencing in research.”38 Karen enlisted several colleagues at NIH to serve as 
supervisors for law students in a non-traditional law school course that was part 
externship, part seminar and part clinic.39 Michael Ulrich, a former student in 
this innovative class, writes about how empowered he felt as a student to have 
the opportunity to work with these genetic experts on cutting edge genetic policy 
issues. He is just one of the many students Karen empowered and inspired in her 
years of health law teaching. 
III. CONCLUSION 
Just as each of the writers in this volume have been touched by the 
generosity, creativity, encouragement and friendship of Karen Rothenberg, so 
have I. As her colleague and friend for the last 32 years I have truly been 
 
 36. Wilfond, supra note 16, at 245. 
 37. KAREN H. ROTHENBERG & LYNN WEIN BUSH, THE DRAMA OF DNA (2014). 
 38. Benjamin E. Berkman, et al., Tribute Essay, Karen Rothenberg’s (Not So) Secret Roles and 
Contributions at the U.S. National Institutes of Health, 22 J. OF HEALTH CARE L. AND POL’Y (2019). 
 39. For a description of the course, see Karen H. Rothenberg and Benjamin E. Berkman, Teaching 
Law Students to be Policymakers: The Health and Science Workshop on Genomic Research, 40 J. L. MED. 
& ETHICS 147 (2012).  
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fortunate. I agree wholly with Ruth Faden who says in her essay, “Karen is the 
best kind of colleague to have, and the best kind of friend.”40 Her friendship is 
something I treasure and hope will continue for many years to come.  
 
 
 40. Ruth Faden, Tribute Essay, Tribute to Karen, 22 J. OF HEALTH CARE L. AND POL’Y (2019). 
